Bullish Options Activity in Teva Pharma (TEVA) Continues -Susquehanna
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Price: $39.18 +0.13%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
EPS Growth %: -10.3%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
EPS Growth %: -10.3%
Join SI Premium – FREE
Susquehanna options strategist Alison Edwards notes a continuation of bullish options activity in Teva Pharma (NYSE: TEVA), as an opening investor bought 18k Jan 15 Calls for $1.39, creating ~1 million shares to buy, following yesterday’s bullish Nov24 13 put selling and Jan 17.5 call buying.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Applied Digital (APLD) October 9 weekly 24.50 and 25 calls active into quarter results
- NFT Limited (MI) halted, news pending
- Fresenius Medical Care (FMS) halted, news pending
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
Susquehanna International Group of CompaniesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
